Log in to save to my catalogue

Letter regarding “Fuzapladib in a randomized controlled multicenter masked study in dogs with presum...

Letter regarding “Fuzapladib in a randomized controlled multicenter masked study in dogs with presum...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6bae9d9ad35645258e859d61852422a7

Letter regarding “Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis”

About this item

Full title

Letter regarding “Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis”

Publisher

Hoboken, USA: John Wiley & Sons, Inc

Journal title

Journal of veterinary internal medicine, 2024-05, Vol.38 (3), p.1282-1284

Language

English

Formats

Publication information

Publisher

Hoboken, USA: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Another limitation is the lack of data on the proportion of dogs treated as outpatients (presenting with milder clinical signs and requiring less care) compared with those requiring intensive care. Because IV fluid administration is the cornerstone of AP treatment, detailed information on the number of dogs receiving fluids (including volume and du...

Alternative Titles

Full title

Letter regarding “Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis”

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6bae9d9ad35645258e859d61852422a7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6bae9d9ad35645258e859d61852422a7

Other Identifiers

ISSN

0891-6640

E-ISSN

1939-1676

DOI

10.1111/jvim.17025

How to access this item